Cargando…

The Prognostic Value of Programmed Death-Ligand 1 in a Chinese Cohort With Clear Cell Renal Cell Carcinoma

Objective: To investigate the association between tumor PD-L1 expression and patient survival to determine whether PD-L1 represents an independent prognostic feature for patients with non-metastatic clear cell renal cell carcinoma (RCC). Patients and Methods: The tissue bank of the Fudan University...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xiao, Wen-jun, Xu, Fu-jiang, Zhang, Xuan, Zhou, Shu-xian, Zhang, Hai-liang, Dai, Bo, Zhu, Yao, Shi, Guo-hai, Shen, Yi-jun, Zhu, Yi-ping, Qu, Yuan-yuan, Zhao, Jian-yuan, Ye, Ding-wei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6886562/ https://www.ncbi.nlm.nih.gov/pubmed/31824835 http://dx.doi.org/10.3389/fonc.2019.00879

Ejemplares similares

The expression and prognostic value of transporter 1, ATP binding cassette subfamily B member in clear cell renal cell cancer with experimental validation
por: Wang, Zhen-Da, et al.
Publicado: (2022)

Prognostic value of epithelial-mesenchymal transition markers in clear cell renal cell carcinoma
por: Xu, Hua, et al.
Publicado: (2020)

Prognostic value and immune infiltration of novel signatures in clear cell renal cell carcinoma microenvironment
por: Xu, Wen-Hao, et al.
Publicado: (2019)

Prognostic value of programmed death-ligand 1 (PD-L1) expression in ovarian clear cell carcinoma
por: Zhu, Jun, et al.
Publicado: (2017)

An Integrated Score and Nomogram Combining Clinical and Immunohistochemistry Factors to Predict High ISUP Grade Clear Cell Renal Cell Carcinoma
por: Wu, Junlong, et al.
Publicado: (2018)

Prognostic Value of Programmed Cell Death 1 Ligand-1 in Patients With Bone and Soft Tissue Sarcomas: A Systemic and Comprehensive Meta-Analysis Based on 3,680 Patients
por: Wang, Feng, et al.
Publicado: (2020)

The Prognostic Value of Circulating Soluble Programmed Death Ligand-1 in Cancers: A Meta-Analysis
por: Huang, Pei, et al.
Publicado: (2021)

Prognostic Value of YTHDF2 in Clear Cell Renal Cell Carcinoma
por: Mu, Zhongyi, et al.
Publicado: (2020)

Prognostic implications of Aquaporin 9 expression in clear cell renal cell carcinoma
por: Xu, Wen-Hao, et al.
Publicado: (2019)

Prognostic and Clinicopathological Value of Programmed Cell Death Ligand1 Expression in Patients With Small Cell Lung Cancer: A Meta-Analysis
por: Cai, Huarong, et al.
Publicado: (2020)

Expression of basement membrane genes and their prognostic significance in clear cell renal cell carcinoma patients
por: Tao, Junyue, et al.
Publicado: (2022)

Identification of prognostic biomarkers in papillary renal cell carcinoma and PTTG1 may serve as a biomarker for predicting immunotherapy response
por: Tian, Xi, et al.
Publicado: (2022)

Prognostic Value of Plasma and Urine Glycosaminoglycan Scores in Clear Cell Renal Cell Carcinoma
por: Gatto, Francesco, et al.
Publicado: (2016)

Prognostic value of neutrophil extracellular trap signature in clear cell renal cell carcinoma
por: Li, Rong, et al.
Publicado: (2023)

A Novel Prognostic Signature Associated With the Tumor Microenvironment in Kidney Renal Clear Cell Carcinoma
por: Pei, Dongchen, et al.
Publicado: (2022)

Prognostic Value of Vimentin Is Associated With Immunosuppression in Metastatic Renal Cell Carcinoma
por: Yao, Jia xi, et al.
Publicado: (2020)

Prognostic value of systemic immune-inflammation index in non-metastatic clear cell renal cell carcinoma with tumor thrombus
por: Gu, Yufeng, et al.
Publicado: (2023)

Potassium channel-related genes are a novel prognostic signature for the tumor microenvironment of renal clear cell carcinoma
por: Zeng, Rui, et al.
Publicado: (2022)

Prognostic value of programmed cell death ligand-1 expression in breast cancer: A meta-analysis
por: Zhang, Yingzi, et al.
Publicado: (2020)

The prognostic value and response to immunotherapy of immunogenic cell death-associated genes in breast cancer
por: Zhao, Rongling, et al.
Publicado: (2023)

Predictive Values of Programmed Cell Death-Ligand 1 Expression for Prognosis, Clinicopathological Factors, and Response to Programmed Cell Death-1/Programmed Cell Death-Ligand 1 Inhibitors in Patients With Gynecological Cancers: A Meta-Analysis
por: Zhang, Chen, et al.
Publicado: (2021)

Expression of Programmed Cell Death-Ligands in Hepatocellular Carcinoma: Correlation With Immune Microenvironment and Survival Outcomes
por: Liao, Haotian, et al.
Publicado: (2019)

Prognostic Value of Galectin-9 Relates to Programmed Death-Ligand 1 in Patients With Multiple Myeloma
por: Lee, Byung-Hyun, et al.
Publicado: (2021)

Prognostic Value of Programmed Cell Death Ligand-1 Expression in Nasopharyngeal Carcinoma: A Meta-Analysis of 1,315 Patients
por: Liu, Xiaofeng, et al.
Publicado: (2019)

Arterial Spin Labeling MRI for Predicting Microvascular Invasion of T1 Staging Renal Clear Cell Carcinoma Preoperatively
por: Zhang, Han-Mei, et al.
Publicado: (2021)

Clear Cell Papillary Renal Cell Carcinoma Shares Distinct Molecular Characteristics and may be Significantly Associated With Higher Risk of Developing Second Primary Malignancy
por: Tian, Xi, et al.
Publicado: (2021)

Prognostic value of programmed death-ligand 1 in sarcoma: a meta-analysis
por: Zhu, Zhenhua, et al.
Publicado: (2017)

Characterization of the basement membrane in kidney renal clear cell carcinoma to guide clinical therapy
por: Xiong, Xi, et al.
Publicado: (2022)

Identification of CXCL10 as a Prognostic Biomarker for Clear Cell Renal Cell Carcinoma
por: Qu, Genyi, et al.
Publicado: (2022)

MRI-Based Grading of Clear Cell Renal Cell Carcinoma Using a Machine Learning Classifier
por: Chen, Xin-Yuan, et al.
Publicado: (2021)

Histone methyltransferase SETD2: An epigenetic driver in clear cell renal cell carcinoma
por: Yu, Mengxue, et al.
Publicado: (2023)

The Inflammasomes Adaptor Protein PYCARD Is a Potential Pyroptosis Biomarker Related to Immune Response and Prognosis in Clear Cell Renal Cell Carcinoma
por: Su, Jia-Qi, et al.
Publicado: (2022)

Integrative Bioinformatics Analysis Demonstrates the Prognostic Value of Chromatin Accessibility Biomarkers in Clear Cell Renal Cell Carcinoma
por: Meng, Meng, et al.
Publicado: (2021)

Mitochondrial metabolic reprogramming-mediated immunogenic cell death reveals immune and prognostic features of clear cell renal cell carcinoma
por: Yang, Lin, et al.
Publicado: (2023)

Comprehensive Analysis of Immune Implication and Prognostic Value of IFI44L in Non-Small Cell Lung Cancer
por: Zeng, Yong, et al.
Publicado: (2022)

Exploring a ferroptosis and oxidative stress-based prognostic model for clear cell renal cell carcinoma
por: Lin, Dongxu, et al.
Publicado: (2023)

Prognostic Value of Tumor-Associated Macrophages in Clear Cell Renal Cell Carcinoma: A Systematic Review and Meta-Analysis
por: Shen, Haixiang, et al.
Publicado: (2021)

Identification of an Autophagy-Related Prognostic Signature for Clear Cell Renal Cell Carcinoma
por: Chen, Mei, et al.
Publicado: (2020)

Comprehensive Analysis of the Expression and Prognosis Value of Chromobox Family Members in Clear Cell Renal Cell Carcinoma
por: Zhu, Yuanyuan, et al.
Publicado: (2021)

Identification of an immune subtype-related prognostic signature of clear cell renal cell carcinoma based on single-cell sequencing analysis
por: Fan, Zongyao, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_uskbid8ptmr2oq6m8s9c8m2fov